Search Bar & Filters
Found 3 Actively Recruiting clinical trials
Actively Recruiting
Researchers are evaluating the effectiveness of traditional physiotherapy combined with gait re-education using the R-Force bodyweight-supported anti-gravity treadmill for people with knee osteoarthritis. This randomized clinical trial involves patients aged 40 to 70 years with moderate knee osteoarthritis grade 2 or 3 confirmed by X-rays and experiencing knee pain for at least 3 months. The study aims to improve walking patterns, joint motion, knee function, quality of life, and body composition. Participants are randomly assigned to one of two groups for a 4-week therapy program conducted three times weekly. One group receives conventional physiotherapy, including exercises for strength, balance, and gait, while the other group receives the same physiotherapy plus training on the R-Force anti-gravity treadmill to reduce joint stress during walking. Each session lasts about 90 minutes. Participants will be assessed before starting treatment, immediately after the 4-week program, and again at 8 weeks. Evaluations include gait analysis on the treadmill, walking tests, joint motion measurements, pain assessments, body composition analysis, and questionnaires about knee function, quality of life, anxiety, and depression. Ultrasound imaging will also be used to assess knee structures. These measurements help researchers understand how the therapies affect participants over time.
Actively Recruiting
Atrial Septal Defect ASD is a type of congenital heart defect that may be closed without open-heart surgery. Traditionally, ASD closure was done surgically, but less invasive options like percutaneous transcatheter occluder devices have become available. This research aims to collect real-world clinical data and confirm the long-term safety and performance of the Lifetech Cera153 ASD Occluder, a device used to close ASD without surgery. The study also seeks to identify any previously unknown side effects of this device. Participants in this study will have received the Lifetech Cera153 ASD Occluder between January 2020 and December 2023, following instructions for use. The study is single-armed and observational, planned under the Regulation EU 2017745. Subjects will be followed up for two years after device implantation to track outcomes and safety. The enrollment period is expected to last about one year with a target of 139 participants. During the study, researchers will monitor procedural success six months after implantation and assess successful closure of the defect immediately after the procedure, at hospital discharge, and at 12 months. They will also track new onset arrhythmias requiring treatment, device or procedure-related adverse events and serious adverse events, as well as any deaths from the time of the procedure up to two years post-implantation. Participants must attend follow-up visits as part of the study, with all data collected and processed with their consent.
Actively Recruiting
Researchers are evaluating the effectiveness of rehabilitation using virtual reality compared with conventional physiotherapy in patients aged 40 to 65 years with chronic low back pain lasting at least three months. This prospective, randomized controlled trial includes 80 participants to reduce variability and assess the impact of virtual reality on physical and psychosocial outcomes in this population. The study focuses on improving movement quality, postural control, and functional mobility while addressing common psychosocial factors such as fear of movement, stress, anxiety, and depression. Participants will be randomly assigned to one of two groups an experimental group receiving conventional rehabilitation combined with non-immersive virtual reality training using the Tecnobody Homing Studio system, and a control group receiving conventional rehabilitation alone. Both groups will complete a standardized four-week rehabilitation program supervised by a physiotherapist. The virtual reality exercises will replace some conventional exercises and provide interactive tasks with visual and auditory biofeedback using a 3D camera for real-time motion analysis. During the study, participants will be assessed at baseline, immediately after the four-week program, and at an eight-week follow-up. Evaluations will include tests of balance, posture, joint mobility, lower limb strength, pain intensity, pressure pain threshold, and psychosocial measures such as kinesiophobia, stress, anxiety, depression, functional disability, quality of life, and motivation for physical activity. Attendance and adherence will be monitored, and any adverse events related to the rehabilitation or virtual reality use will be recorded. The trial aims to provide evidence on virtual reality-assisted rehabilitations role in managing chronic low back pain.